Neoadjuvant Chemoimmunotherapy Does Not Increase Postoperative Morbidity of Pneumonectomy in NSCLC Patients: A Multi-Center Psmanalysis

被引：0

作者：

Li, Z. ^{[1
]}

He, W. ^{[1
]}

机构：

[1] Shanghai Pulm Hosp, Shanghai, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

pneumonectomy; non-small cell lung cancer; Neoadjuvant chemoimmunotherapy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP.08D.06

引用

页码：S570 / S570

页数：1

共 50 条

[21] Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study
Qin, Yi
Long, Yaling
Tang, Yuan
Tian, Yuke
Li, Juan
Duan, Ping
Luo, Jieyan
Yu, Min
Li, Yanying
Zhou, Xiaojuan
Wang, Ke
Gong, Youling
Peng, Feng
Zhu, Jiang
Liu, Yongmei
Zhou, Lin
Lu, You
Huang, Meijuan
CANCER SCIENCE, 2023, 114 (06) : 2552 - 2559
[22] Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Single-Arm, Phase II Multi-Center Trial
Park, S.
Ahn, H. K.
Lee, S.
Min, Y. J.
Jung, H. A.
Sun, J. -M.
Lee, S-H.
Ahn, J. S.
Ahn, M. -J.
Lee, J. B.
Kim, S. M.
Kim, H. R.
Cho, B. C.
Hong, M. H.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S148 - S149
[23] RET-MAP: An international multi-center study on clinicopathologic features and treatment response in patients with NSCLC and RET fusions
Marinello, A.
Duruisseaux, M.
Zrafi, W. S.
Dall'Olio, F. G.
Massa, G.
Iranzo, P.
Tabbo, F.
Guisier, F.
Lindsay, C.
Fallet, V.
Audigier-Valette, C.
Mezquita, L.
Calles, A.
Mountzios, G.
Tagliamento, M.
Raimbourg, J.
Terrisse, S.
Planchard, D.
Besse, B.
Aldea, M.
ANNALS OF ONCOLOGY, 2022, 33 : S47 - S48
[24] DOES COMPLETE PATHOLOGICAL RESPONSE INCREASE PERIOPERATIVE MORBIDITY RISK IN PATIENTS UNDERGOING RESECTION FOR RECTAL CANCER FOLLOWING NEOADJUVANT TREATMENT?
Tiang, T.
Proud, D.
DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
[25] Does non-alcoholic fatty liver disease increase the risk for pancreatic cancer? A multi-center retrospective cohort study
Singh, Rituraj Raj
O'Reilly, Eileen M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[26] Real-word efficacy of osimertinib in patients with metastatic EGFRm NSCLC: An interim analysis from a multi-center study in China
Ye, X.
Lu, S.
ANNALS OF ONCOLOGY, 2019, 30
[27] Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study
Shigeta, Keisuke
Matsumoto, Kazuhiro
Ogihara, Koichiro
Murakami, Tetsushi
Anno, Tadatsugu
Umeda, Kota
Izawa, Mizuki
Baba, Yuto
Sanjo, Tansei
Shojo, Kazunori
Tanaka, Nobuyuki
Takeda, Toshikazu
Morita, Shinya
Kosaka, Takeo
Mizuno, Ryuichi
Arita, Yuki
Akita, Hirotaka
Jinzaki, Masahiro
Kikuchi, Eiji
Oya, Mototsugu
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (03) : 105.e19 - 105.e26
[28] Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study
Zhang, Kun
Zhang, Lei
Li, Wen-Cui
Xie, Shuang-Shuang
Cui, Ying-Zhu
Lin, Li-Ying
Shen, Zhi-Wei
Zhang, Hui-Mao
Xia, Shuang
Ye, Zhao-Xiang
He, Kan
Shen, Wen
EUROPEAN RADIOLOGY, 2023, 33 (12) : 8936 - 8947
[29] Artificial intelligence-assisted delineation for postoperative radiotherapy in patients with lung cancer: a prospective, multi-center, cohort study
Han, Ziming
Wang, Yu
Wang, Wenqing
Zhang, Tao
Wang, Jianyang
Ma, Xiangyu
Men, Kuo
Shi, Anhui
Gao, Yuyan
Bi, Nan
FRONTIERS IN ONCOLOGY, 2024, 14
[30] Performing Omentectomy During Gastrectomy Does Not Improve Survival: a Multi-Center Analysis of 471 Patients with Gastric Adenocarcinoma
Stephanie Young
L. Andrew DiFronzo
Ashim Ahuja
Lauren Keim
Curtis Papenfuss
Victoria O’Connor
Ahmed Dehal
Journal of Gastrointestinal Surgery, 2020, 24 : 2856 - 2858

← 1 2 3 4 5 →